A MEDICAL APPRAISAL OF THERAPY FOR OCCLUSIVE ARTERIAL DISEASE.
D001162:Arteriosclerosis Obliterans; D001783:Blood Flow Velocity; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation; D004088:Dihydroergotoxine; D004837:Epinephrine; D004876:Ergot Alkaloids; D005081:Exercise Therapy; D005734:Gangrene; D006358:Hot Temperature; D006801:Humans; D006940:Hyperemia; D007269:Injections, Intra-Arterial; D007383:Intermittent Claudication; D010208:Papaverine; D010627:Phenethylamines; D013562:Sympathectomy; D014043:Tolazoline; D014656:Vascular Surgical Procedures; D014665:Vasodilator Agents
D004876:Ergot Alkaloids; D010627:Phenethylamines; D014665:Vasodilator Agents; D004088:Dihydroergotoxine; D014043:Tolazoline; D010208:Papaverine; D004837:Epinephrine
ARTERIOSCLEROSIS OBLITERANS; BLOOD FLOW VELOCITY; BLOOD VESSEL PROSTHESIS; EPINEPHRINE; ERGOT ALKALOIDS, HYDROGENATED; EXERCISE THERAPY; GANGRENE; HEAT; HYPEREMIA; INJECTIONS, INTRA-ARTERIAL; INTERMITTENT CLAUDICATION; PAPAVERINE; PHENETHYLAMINES; SYMPATHECTOMY; TOLAZOLINE; VASCULAR SURGERY; VASODILATOR AGENTS